| 000 | 01299 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512213142.0 | ||
| 264 | 0 | _c19840107 | |
| 008 | 198401s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeaman, W E | |
| 245 | 0 | 0 |
_aHuman natural killer cell activity is reversibly inhibited by antagonists of lipoxygenation. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cDec 1983 |
||
| 300 |
_a2953-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _a4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aCatechols _xpharmacology |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 | _aLipoxygenase Inhibitors |
| 650 | 0 | 4 | _aMasoprocol |
| 650 | 0 | 4 |
_aMonocytes _ximmunology |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xblood |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 131 _gno. 6 _gp. 2953-7 |
|
| 999 |
_c6417124 _d6417124 |
||